Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance

C Alberti
European Review for Medical and Pharmacological Sciences  
In patients with androgeri-sensitive prostate cancer androgen-deprivation therapy leads to apoptosis of hormone-dependent cells but it may select out androgen-refractory clones. The apoptosis of prostate cancer cells induced by quinazoline-derived alpha1-adrenoceptor antagonists (doxazosin, terazosin, prazosin) counteracts cell proliferation and may have the potential of reversing or delaying prostate cancer growth. Elucidation of the biomolecular mechanisms whereby
more » ... or-antagonists are able to induce anoikis and apoptosis in androgen-refractory prostate cancer cells would be favorable for designing effective therapeutic regimens in the management of advanced prostate cancer.
pmid:17405349 fatcat:f7bvxvnjxzd4vgxtchzecmsnza